Main menu

Spanish-language webinar: Integrating Nanopore Sequencing Into Clinical Research - Case Studies in Pathogen, Cancer and Genomics Analysis


Long-read sequencing provides advantages over short reads for a multitude of applications including characterising pathogens, analysing cancer genomic alterations and accurately detecting structural variants in the human genome.

In this webinar, Dr. Alfredo Hidalgo Miranda demonstrates the potential and flexibility of Oxford Nanopore Technologies’ sequencing platforms in cancer and infectious disease research. He showcases the use of the Oxford Nanopore sequencing platform to sequence SARS-CoV-2 and Mycobacterium tuberculosis to monitor viral evolution and drug resistance. Dr. Hidalgo Miranda also highlights the transcriptomic analysis, characterisation of chromosomal translocations and the identification of mutations with diagnostic potential in lymphoblastic leukemia samples.

Authors: Alfredo Hidalgo Miranda, PhD Principal Investigator at Instituto Nacional de Medicina Genomica Dr. Alfredo Hidalgo Miranda is a Biologist and a PhD in Biomedical research. His current work at the Cancer Genomics laboratory of the Mexican National Institute of Genomic Medicine, is focused on the analysis of genomic and transcriptomic alterations in human tumours, particularly breast cancer. He has recently incorporated long-read sequencing analysis to improve the characterisation of genomic diversity in the Mexican population and the analysis of cancer and rare diseases.

入門

MinION Starter Packを購入 ナノポア製品の販売 シークエンスサービスプロバイダー グローバルディストリビューター

ナノポア技術

ナノポアの最新ニュースを購読 リソースと発表文献 Nanopore Communityとは

Oxford Nanoporeについて

ニュース 会社沿革 持続可能性 経営陣 メディアリソース & お問い合わせ先 投資家向け パートナー向け Oxford Nanopore社で働く 現在の募集状況 営業上の情報 BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
Japanese flag